SIEGFRIED BARBERA

Siegfried is a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical industry, with a global network of 13 production sites across three continents. Its core business is the production of active pharmaceutical ingredients (APIs), intermediates, and finished pharmaceutical products, integrating services from process development to manufacturing, packaging, and logistics.

Founded in 1873 in Zofingen, Switzerland, Siegfried began as a company that produced and marketed chemical and pharmaceutical preparations. From its inception, it focused on third-party manufacturing, establishing a contract manufacturing business model. Throughout its history, the company has undergone several strategic transformations, focusing since the 1980s on the development and production of active pharmaceutical ingredients and products for the pharmaceutical industry. Since 2010, Siegfried has grown significantly through acquisitions, expanding its global network and technological capabilities. It currently operates in 13 locations across seven countries, with significant milestones including the acquisition of sites in Spain and the United States, and expansion into biotechnology and gene therapies.

Siegfried offers integrated contract development and manufacturing services for active pharmaceutical ingredients (APIs), intermediates, finished dosage forms (such as oral solids, sterile injectables, ophthalmic products, and inhalers), and gene therapy solutions through its subsidiary DINAMIQS. Key products and services include API production (including controlled and high-potency substances), sterile and injectable product development and manufacturing, ophthalmic formulations, oral solids, and inhalation, as well as analytical development, regulatory, and supply chain management services.

Siegfried's mission is to bring its pharmaceutical clients' innovations to industrial scale through mastery of science and technology, manufacturing safe medicines for patients worldwide. Its vision is to be the pharmaceutical industry's most trusted partner and the global leader in the CDMO sector, operating the most competitive network with the strongest team.